Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...
New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.
A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...
Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...
Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...
aWallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Mölndal, Sweden bDepartment of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden ...
Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...
Introduction: Healthcare disruptions imposed by the coronavirus disease (COVID-19) pandemic and possible biological links between SARS-CoV-2 and prion misfolding might influence the prevalence or ...
Plasma measures of phosphorylated tau217 (p-tau217) can accurately identify individuals in the preclinical stage of Alzheimer’s disease (AD), a new meta-analysis showed. The results are important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback